Searched for
SANTOSH VARALWAR
Vivimed Labs gets additional $7.5 million funding from OrbiMed AsiaThe company had earlier received USD 42.5 million from OrbiMed Asia in September 2017, Vivimed Labs said in a BSE filing.- Vivimed to sell some speciality chemicals products to ClariantDrug firm Vivimed Labs has signed a pact for sale of some of products in its speciality chemicals division to Clariant Chemicals India.
- Vivimed acquires Actavis Pharma's facility for Rs 122 croreVivimed Labs today said it has acquired a manufacturing facility of Actavis Pharma Manufacturing Ltd for a total consideration of Rs 122 cr.
- Vivimed acquires Uquifa for $ 55 million"In a move to bring in strategic growth into its product mix and expand the footprint in Europe and the US, the co has taken a measured str...
- Not looking for any QIP right now: Santosh Varalwar, CMD, Vivimed LabsET Now spoke with Santosh Varalwar, CMD, Vivimed Labs, on the speciality chemical maker's order book structures, capex requirements & possi...
Load More- Vivimed acquires Uquifa for $ 55 million